WHO BENEFITS FROM IPV® ?

1. All age groups with Bronchiectasis
2. All age groups with Cystic Fibrosis and Fibrocystic lung disease
3. Patients with acute and chronic obstructive pulmonary diseases
4. Patients with Cor Pulmonale or with Chronic Bronchitis complicated by left congestive heart failure.
5. Burn patients with pulmonary involvement
6. Post surgical patients with retained endobronchial secretions and diffuse patchy atelectasis including patients with heart lung transplants.
7. Myopathic children with congenital or acquired mechanical breathing limitations
8. Neonates with retained endobronchial secrtions and/or with diffuse atelectasis.
   

Intrapulmonary Percussive Ventilation (IPV®) is a therapeutic concept for the acute or chronic care patients displaying the typical symptoms of Obstructive Pulmonary Diseases. The major advantage for patients using IPV therapy, is the ability to perform his or her own percussive therapy on their own schedule. When the patient maintains control of their airway clearance program, this may reflect better overall respiratory therapy, thus decreasing the incidence of infections that would normally require hospitalization.